ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yongkun Sun
Matched on ORCID iD 0000-0003-3302-6023; OpenAlex author ID A5037865142. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12876-025-03867-2↗
- Recent advances in targeted therapy for pancreatic adenocarcinoma. Last author DOI 10.4251/wjgo.v15.i4.571↗
- Long-term survival of a patient with pancreatic cancer and lung metastasis: A case report and review of literature. Last author DOI 10.12998/wjcc.v9.i30.9134↗
- Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. Co-author DOI 10.1007/s00280-018-3650-4↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuting Fang · 2 shared papers, 2023–2025 · strength 0.55
- Wenwei Yang · 2 shared papers, 2021–2023 · strength 0.46
- Wenjie Liu · 1 shared paper, 2025 · strength 0.28
- Haizhen Lu · 1 shared paper, 2021 · strength 0.19
- Wen Zhang · 1 shared paper, 2018 · strength 0.08
- Aiping Zhou · 1 shared paper, 2018 · strength 0.08
- Chengfeng Wang · 1 shared paper, 2018 · strength 0.08
- Chunxia Du · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.